Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCPH | A | Deciphera Pharmaceuticals, Inc. | 0.00 | |
FUSN | A | Fusion Pharmaceuticals Inc. | 0.00 | |
ALNY | A | Alnylam Pharmaceuticals, Inc. | 0.94 | |
GMED | B | Globus Medical, Inc. | 0.20 | |
KRYS | B | Krystal Biotech, Inc. | 3.82 | |
ICLR | B | ICON plc | 0.87 | |
AXSM | B | Axsome Therapeutics, Inc. | 2.26 | |
PULM | B | Pulmatrix, Inc. | -3.65 | |
TGTX | B | TG Therapeutics, Inc. | 1.17 | |
LDOS | B | Leidos Holdings, Inc. | -0.77 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XBI | C | SPDR S&P Biotech ETF | 3.76 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 3.05 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 2.91 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 2.64 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 2.44 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles